Please ensure Javascript is enabled for purposes of website accessibility

Pharmaceutical Wastewater Treatment

A worker in protective clothing operates machinery to inspect pills on a production line in a pharmaceutical manufacturing facility.

Table of Contents

Pharmaceutical wastewater isn’t like industrial wastewater from other sectors. Its complexity stems from the sheer diversity of compounds involved. A single facility might discharge wastewater containing:

  • Active pharmaceutical ingredients (APIs) – biologically active molecules that persist in water environments and disrupt aquatic ecosystems
  • Organic solvents – used in synthesis and extraction processes
  • Disinfectants and cleaning agents – including quaternary ammonium compounds
  • Heavy metals – from catalyst use or equipment corrosion
  • High biological oxygen demand (BOD) and chemical oxygen demand (COD) – from fermentation byproducts and organic compounds

Many of these contaminants are resistant to conventional biological treatment. APIs, in particular, pass through standard treatment processes largely intact ending up in rivers, groundwater, and eventually drinking water supplies.

This makes pharmaceutical wastewater a regulatory and environmental priority and a technical challenge that demands specialized expertise.

Custom system design: Pharmaceutical wastewater profiles vary significantly between facilities and even between production batches. We conduct a detailed wastewater characterization before recommending any treatment approach ensuring the system is matched to actual effluent conditions rather than generic assumptions.

Technology integration: Rather than defaulting to a single technology, our engineers at Meb designs integrated treatment plans that combine biological, chemical, and physical processes. This multi-barrier approach delivers more robust performance across varying wastewater compositions.

Ongoing support: A treatment system is only as good as its operation. At Meb we provide monitoring, maintenance, and performance optimization services to ensure systems continue to meet discharge standards as regulations evolve and production processes change.

At Meb we work with pharmaceutical clients at every stage of this journey from initial feasibility assessment through to full system operation. Whether a facility is looking to achieve first-time compliance, upgrade legacy infrastructure, or pursue water reuse goals, Meb brings the technical depth and practical experience to make it happen.

 

 

 

Share:

Case Study

A revolutionary approach to water supply

To cope with a crippling and prolonged drought crisis, MEB installed a containerized desalination plant at Richards Bay, South Africa. The project was completed in just seven months. The containers were easily transported to the designated location.1

More Posts

Related Posts
A rounded, teardrop-shaped glass form covered in water droplets against a blue gradient background.
Renewing Our Water Crises In South Africa

South Africa is working to strengthen its water infrastructure by improving municipal capacity and project coordination. However, poor governance in national water services has taken

Clean Water Brighter Futures

Millions of people living in South Africa’s informal settlements still lack access to clean water and safe sanitation. The consequences ripple across every part of

A white shipping container labeled "Water out of the Box. NIROBOX" on its side, with closed doors and metallic reinforcements—an innovative unit featured in Amazing Facts about Desalination and the NIROBOX™.
Smart Water Solutions Delivered Faster

Choosing a decentralized, containerized system offers several distinct advantages over conventional desalination plants. Smaller modular units can be deployed closer to water-stressed communities, reducing the